Deafness, Sensorineural, Autosomal-Mitochondrial Type
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
|
|
|
Myopathy
|
0.400 |
Biomarker
|
group |
HPO |
|
|
|
MERRF Syndrome
|
0.300 |
GeneticVariation
|
disease |
ORPHANET |
|
|
|
Sensorineural Hearing Loss (disorder)
|
0.130 |
Biomarker
|
disease |
HPO |
|
|
|
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Movement Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Optic Atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Impaired cognition
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Short stature
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Electromyogram abnormal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Multiple lipomata
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
DEAFNESS, AMINOGLYCOSIDE-INDUCED
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Short Stature, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ragged-red muscle fibers
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Generalized myoclonic seizures
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Bacterial Vaginosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
<i>Results.</i> In spontaneous abortion women, 16 S rRNA gene sequences showed significant increases in <i>Atopobium vaginae</i>, <i>Megasphaera</i> spp., <i>Gardnerella vaginalis</i>, <i>Leptotrichia amnionii</i>, and <i>Sneathia sanguinegens</i> compared to women in nonabortion group.
|
29479540 |
2017 |
Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Tumor also presented substantially more variants in the following regions: MT-RNR1, MT-ND5, MT-ND4, MT-ND2, MT-DLOOP1 and MT-CO1.
|
31673122 |
2019 |
Hyperinsulinism
|
0.010 |
Biomarker
|
disease |
BEFREE |
Mitochondrial open reading frame of the 12S rRNA-c (MOTS-c) is a mitochondrial-derived peptide that attenuates weight gain and hyperinsulinemia when administered to high fat-fed mice.
|
29593067 |
2018 |
Vascular calcification
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Mitochondrial-Derived Peptide MOTS-c Attenuates Vascular Calcification and Secondary Myocardial Remodeling via Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway.
|
31694019 |
2020 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.010 |
Biomarker
|
disease |
BEFREE |
A novel bioactive peptide, mitochondrial-derived peptide (MOTS-c), has recently attracted attention as a potential prevention or therapeutic option for obesity and type 2 diabetes mellitus (T2DM).
|
29691953 |
2018 |
Tinnitus
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A novel mitochondrial mutation, 1556C --> T, in a Japanese patient with streptomycin-induced tinnitus.
|
15141753 |
2004 |
Tinnitus, Subjective
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A novel mitochondrial mutation, 1556C --> T, in a Japanese patient with streptomycin-induced tinnitus.
|
15141753 |
2004 |
Tinnitus, Objective
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A novel mitochondrial mutation, 1556C --> T, in a Japanese patient with streptomycin-induced tinnitus.
|
15141753 |
2004 |
Tinnitus of Vascular Origin
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A novel mitochondrial mutation, 1556C --> T, in a Japanese patient with streptomycin-induced tinnitus.
|
15141753 |
2004 |